C
Pediatrix Medical Group, Inc. MD
$19.70 -$0.19-0.96% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Pediatrix Medical Group, Inc. is a physician-led healthcare services company focused on providing specialized medical care for women, infants, and children. The company operates primarily within the healthcare services industry, delivering care in hospital-based and outpatient settings through long-term service agreements with healthcare facilities. Its core activities center on neonatal, maternal-fetal, and pediatric subspecialty care, making it a key provider within perinatal and pediatric medicine in the United States.

The company generates the majority of its revenue from professional medical services reimbursed by commercial insurers, government healthcare programs, and managed care organizations. Pediatrix Medical Group evolved from its former corporate identity, MEDNAX, Inc., and formally adopted the Pediatrix Medical Group name to reflect its strategic refocus on its historical strengths in neonatology and pediatric subspecialties after divesting non-core service lines. Its strategic positioning emphasizes clinical depth, scale, and long-standing hospital partnerships.

Business Operations

Pediatrix Medical Group’s operations are organized around its physician practice management model, supporting affiliated clinicians with administrative, billing, compliance, and clinical infrastructure. Its primary business segments include Neonatology, Maternal-Fetal Medicine, Pediatric Cardiology, Pediatric Intensive Care, Pediatric Hospital Medicine, and Obstetric Services, which collectively represent the company’s principal revenue drivers.

The company operates almost entirely within the United States and provides care across hundreds of hospitals and outpatient clinics. Pediatrix controls centralized clinical support systems, revenue cycle management platforms, and quality reporting infrastructure through its operating subsidiary Pediatrix Medical Services, Inc. The company maintains contractual relationships with hospitals rather than owning facilities, enabling an asset-light operating model.

Strategic Position & Investments

Pediatrix Medical Group’s strategic direction is centered on deepening its leadership in neonatal and pediatric subspecialty care while improving operational efficiency and clinical outcomes. The company has emphasized organic growth through expanding service offerings within existing hospital partnerships and recruiting subspecialist physicians in high-demand pediatric fields.

In recent years, Pediatrix completed divestitures of its former anesthesiology and radiology businesses to sharpen its focus on women’s and children’s healthcare. The company continues to invest in clinical data analytics, telemedicine capabilities, and quality improvement initiatives designed to support value-based care arrangements. Data inconclusive based on available public sources regarding material acquisitions following the completion of these divestitures.

Geographic Footprint

Pediatrix Medical Group is headquartered in Florida and maintains a broad operational presence across the United States, serving hospitals and clinics in numerous states. Its physicians practice in urban, suburban, and regional healthcare systems, providing the company with nationwide coverage in neonatal and pediatric subspecialty services.

The company does not report material international operations, and its revenue is overwhelmingly derived from U.S.-based healthcare services. Its geographic influence is primarily defined by regional hospital networks and long-standing service contracts rather than owned international assets.

Leadership & Governance

Pediatrix Medical Group is led by an executive team with extensive experience in physician practice management, healthcare operations, and clinical leadership. The company emphasizes a physician-led governance model focused on clinical quality, operational discipline, and alignment with hospital partners.

Key members of the leadership team include:

  • Mark S. OrdanChief Executive Officer
  • Brian C. DeckerChief Financial Officer
  • Jeffrey R. Steinhubl, MDChief Medical Officer
  • Jill C. BrownChief Administrative Officer
  • Craig S. McKeeverChief Compliance Officer

The leadership team’s strategic vision centers on reinforcing Pediatrix’s position as a leading provider of specialized care for women and children while adapting to evolving reimbursement models and healthcare delivery trends.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $172.70
B
AAPL NASDAQ $247.99
B
MSFT NASDAQ $381.87
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $119.02
B
Top Financial Stocks
See All »
B
B
JPM NYSE $286.56
B
V NYSE $301.62
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $53.46
Top Health Care Stocks
See All »
B
LLY NYSE $906.70
B
JNJ NYSE $235.37
B
AMGN NASDAQ $347.80
Top Real Estate Stocks
See All »
B
PLD NYSE $128.01